Home » Topics » BioWorld Science

BioWorld Science
RSS

First-in-human data on FDL-176 in healthy subjects presented

June 12, 2018

EMA grants PRIME designation for Themis' Chikungunya vaccine

June 12, 2018

Merck KGaA reports promising phase II data for tepotinib in advanced HCC

June 12, 2018

Lilly and AstraZeneca discontinue phase III trials of lanabecestat for Alzheimer's disease

June 12, 2018

Phase III data support ibrutinib/rituximab combination in Waldenstrom's macroglobulinemia

June 12, 2018

Boehringer Ingelheim initiates phase I study of BI-907828 in solid tumors

June 12, 2018

Significant improvements in ulcerative colitis seen with apremilast in phase II trial

June 12, 2018

FDA grants fast track designation to Betalutin for relapsed or refractory follicular lymphoma

June 12, 2018

Preliminary data presented from interim review of phase I/II study of OXS-1550

June 12, 2018

Atogepant demonstrates efficacy and safety in phase IIb/III study in episodic migraine

June 12, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...